date,title,source
Oct-18-18,Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings,GlobeNewswire
Oct-22-18,Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346,GlobeNewswire
Oct-25-18,Allena Pharmaceuticals to Present Data Characterizing Significant Unmet Need in Enteric Hyperoxaluria at ASN Kidney Week 2018,GlobeNewswire
Nov-06-18,Allena Pharmaceuticals to Present at Upcoming Investor Conferences in November,GlobeNewswire
Nov-07-18,Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-19-18,"Recent Analysis Shows Arcimoto, ADOMANI, Lipocine, Aileron Therapeutics, Allena Pharmaceuticals, and Perma-Fix Environmental Services Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Jan-02-19,Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria,GlobeNewswire
Jan-04-19,"Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019",GlobeNewswire
Mar-05-19,"Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference",GlobeNewswire
Mar-07-19,Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update,GlobeNewswire
Mar-27-19,Allena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 Trial,GlobeNewswire
Apr-17-19,Investors Who Bought Allena Pharmaceuticals (NASDAQ:ALNA) Shares A Year Ago Are Now Down 52%,Simply Wall St.
Apr-17-19,Allena Pharmaceuticals Appoints Allene Diaz to its Board of Directors,GlobeNewswire
May-08-19,"All You Need to Know About Allena Pharmaceuticals, Inc. (ALNA) Rating Upgrade to Buy",Zacks
May-08-19,Allena Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update,GlobeNewswire
